Stockreport

Ionis Announces Pivotal Phase 3 Trial Design for ION582 in Angelman Syndrome

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com